trial
as of 2026-07-01Minocycline add-on to Antipsychotics for the Treatment of Negative and Cognitive Symptoms in Schizophrenia
NCTId NCT02907437
at a glance
Phase 3 · Unknown
Enrollment 40 (estimated)
Sponsored by Beer Yaakov - Ness Ziona Mental Health Center
Primary completion 2017-02
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 3
Status
Unknown
Enrollment
40 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2015-01
Primary completion
2017-02
Eligibility
ALL · 18 Years · 60 Years
Interventions & indications
Sponsors
Beer Yaakov - Ness Ziona Mental Health CenterLead Sponsor
Bar-Ilan University, IsraelCollaborator
Investigators
1
Rafael Octavio Stryjer, MDPrincipal Investigator
Sites
1 total
Beer Yaakov, Israel
Linked catalysts
1
Facts & assertions
4 sourced
Enrollment
40
Phase
PHASE3
Primary Completion Date
2017-02
Status
UNKNOWN
relationships
The graph out of here
drug
drug
drug
lead_sponsor
collaborator
company
indication
investigator